SCHEMBL572182

SCHEMBL572182

C[C@H]1OC(Oc2c(-c3ccc(O)cc3)oc3cc(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c2=O)[C@@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 7/20 0.79
AKR1B1 P15121 3/20 0.79
CA12 O43570 2/20 0.79
CA2 P00918 2/20 0.79
CA4 P22748 2/20 0.79
CA7 P43166 2/20 0.79
ACHE P22303 1/20 0.79
NQO2 P16083 1/20 0.75
GAA P10253 5/20 0.75
POLB P06746 4/20 0.75
L3MBTL1 Q9Y468 3/20 0.75
APEX1 P27695 2/20 0.75
RECQL P46063 2/20 0.75
XDH P47989 2/20 0.75
EPHX2 P34913 3/20 0.70
RPS6KA3 P51812 2/20 0.69
KDM4E B2RXH2 4/20 0.69
MAPT P10636 2/20 0.68
ALPL P05186 2/20 0.68
ALPI P09923 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9993267 1.00 P4HB (0.79) P4HBAKR1B1CA12CA2CA4
SCHEMBL30456667 1.00 P4HB (0.79) P4HBAKR1B1CA12CA2CA4
SCHEMBL31720497 1.00 P4HB (0.79) P4HBAKR1B1CA12CA2CA4
SCHEMBL30217549 1.00 P4HB (0.79) P4HBAKR1B1CA12CA2CA4
SCHEMBL30637576 1.00 P4HB (0.79) P4HBAKR1B1CA12CA2CA4
SCHEMBL2164091 0.97 P4HB (0.73) P4HBAKR1B1CA12CA2CA4
SCHEMBL31236368 0.95 P4HB (0.84) P4HBAKR1B1CA12CA2CA4
SCHEMBL31236361 0.95 P4HB (0.84) P4HBAKR1B1CA12CA2CA4
SCHEMBL30106662 0.95 P4HB (0.84) P4HBAKR1B1CA12CA2CA4
SCHEMBL31236369 0.95 P4HB (0.84) P4HBAKR1B1CA12CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 P4HB 3209/4885AKR1B1 1043/4885CA12 1642/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 P4HB 3209/4885AKR1B1 1043/4885CA12 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.